Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,265

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

September 30, 2030

Conditions
Breast Cancer Female
Interventions
RADIATION

HYPOFRACTIONATED

40 Gy/ 15 fractions / 3 weeks

RADIATION

NORMOFRACTIONATED

50 Gy/ 25 fractions / 5 weeks

Trial Locations (28)

13273

Institut Paoli Calmettes, Marseille

25030

Hôpital Jean Minjoz, Besançon

34298

ICM Val d'Aurelle, Montpellier

37044

CHU Bretonneau, Tours

56100

Hôpital du Scorff, Lorient

59800

Centre Galilée - Hôpital Privé La Louvière, Lille

80090

Clinique de l'Europe, Amiens

87039

Clinique Chenieux, Limoges

92309

Centre de radiothérapie Hartmann, Levallois-Perret

Unknown

Institut de Cancerologie de L'Ouest-Paul Papin, Angers

Institut Bergonie, Bordeaux

Centre Jean Perrin, Clermont-Ferrand

Hoptal Henri Mondor, Créteil

Centre Georges Francois Leclerc, Dijon

Centre Guillaume Le Conquerant, Le Havre

Centre Oscar Lambret, Lille

Centre Leon Berard, Lyon

Institut de Cancerologie de Lorraine, Nancy

Hopital Saint-Louis, Paris

Institut Curie, Paris

Centre Eugene Marquis, Rennes

Centre Henri Becquerel, Rouen

Institut Curie- Rene Huguenin, Saint-Cloud

Institut de Cancerologie de L'Ouest-Rene Gauducheau, Saint-Herblain

Centre Paul Strauss, Strasbourg

Institut Claudius Regaud, Toulouse

Gustave Roussy, Villejuif

06189

Centre Antoine Lacassagne, Nice

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

lead

UNICANCER

OTHER

NCT03127995 - Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence | Biotech Hunter | Biotech Hunter